rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-11-30
|
pubmed:abstractText |
The mutational constitutive activation of FGFR3 has been discovered in several malignancies but only limited data on FGFR3 mutations in prostate cancer are available. Most recently, activating FGFR3 mutations were described as being associated with low-grade prostate tumors. Therefore, we investigated the FGFR3 mutation status in a comprehensive series of prostate tumors.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1423-0291
|
pubmed:author |
pubmed-author:BorchardtAlbertA,
pubmed-author:GaisaNadine TNT,
pubmed-author:GiedlChristianC,
pubmed-author:HafnerChristianC,
pubmed-author:HartmannArndtA,
pubmed-author:KeckBastianB,
pubmed-author:KneitzBurkhardB,
pubmed-author:KoufouStellaS,
pubmed-author:LunzJens-ClaudioJC,
pubmed-author:RauTilman TTT,
pubmed-author:RoglerAnjaA,
pubmed-author:StoehrRobertR,
pubmed-author:WielandWolf FWF
|
pubmed:copyrightInfo |
Copyright © 2010 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
249-52
|
pubmed:meshHeading |
pubmed-meshheading:21116115-Aged,
pubmed-meshheading:21116115-Aged, 80 and over,
pubmed-meshheading:21116115-DNA Mutational Analysis,
pubmed-meshheading:21116115-Humans,
pubmed-meshheading:21116115-Male,
pubmed-meshheading:21116115-Middle Aged,
pubmed-meshheading:21116115-Mutation,
pubmed-meshheading:21116115-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:21116115-Prostatic Neoplasms,
pubmed-meshheading:21116115-Receptor, Fibroblast Growth Factor, Type 3
|
pubmed:year |
2010
|
pubmed:articleTitle |
Mutational activation of FGFR3 is not involved in the development of prostate cancer.
|
pubmed:affiliation |
Department of Urology, University of Regensburg, Regensburg, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|